There is a famous old joke in research: asking a statistician for help after the experiment is finished is like asking a doctor to perform an autopsy. The doctor may be brilliant, kind, and armed with excellent coffee, but the patient is still dead. The same thing happens when researchers consult a biostatistician only after the samples are collected, the spreadsheet is glowing with mysterious columns, and someone has already whispered, “Can we just run a t-test?”
If you want to avoid that tragicomic moment, this guide is for you. More specifically, it is a guide to doing everything wrong, so you can recognize the warning signs before your promising experiment turns into a statistical escape room. Whether you work in biomedical research, psychology, public health, animal studies, clinical trials, or a small lab where the freezer has more labels than your data file, consulting your biostatistician before doing an experiment can protect your time, budget, ethics approval, and scientific credibility.
The main lesson is simple: biostatistics is not a decorative garnish sprinkled on top of results. It is part of experimental design. A good biostatistician helps translate a scientific question into a testable hypothesis, choose the right outcome measures, plan randomization and blinding, estimate sample size, prevent avoidable bias, and build an analysis plan before the data start talking back.
Why Researchers Wait Too Long to Consult a Biostatistician
Many researchers do not avoid biostatisticians because they dislike statistics. They avoid them because they think statistics begins after data collection. In reality, the statistical life of an experiment begins the moment someone says, “I wonder whether this treatment works.” That sentence already contains a study population, comparison group, outcome, effect size, measurement schedule, and analysis problem hiding in plain sight.
Another reason people wait is fear. They worry the biostatistician will say the study is underpowered, the design is messy, or the data collection form needs rebuilding. Unfortunately, those discoveries are far cheaper before the experiment than after it. A painful planning meeting in March is better than a failed manuscript in November.
The Worst Ways to Consult Your Biostatistician
1. Arrive After Data Collection and Ask for “Significance”
The most classic mistake is collecting all the data first and then asking, “Can you make this significant?” This is not statistical consulting. This is statistical necromancy, and most reputable biostatisticians are not licensed wizards.
A biostatistician can analyze completed data, but they cannot retroactively randomize participants, repair missing controls, increase sample size, prevent measurement bias, or add outcomes that were never collected. If your study design cannot answer the research question, no p-value can rescue it. At best, the statistician can explain the limitations clearly. At worst, the project becomes a cautionary tale told at future lab meetings, possibly with dramatic lighting.
2. Ask for Sample Size Without Explaining the Research Question
“How many samples do I need?” sounds like a simple question. It is not. It is more like asking, “How much food should I buy?” The answer depends on whether you are feeding two people, a wedding party, or a football team that has just discovered pasta.
A sample size calculation depends on the primary outcome, study design, expected variability, meaningful effect size, statistical power, significance level, allocation ratio, repeated measurements, attrition, clustering, and feasibility. If you cannot explain what difference would be scientifically or clinically meaningful, the biostatistician cannot produce a useful sample size estimate. They can produce a number, but so can a fortune cookie.
3. Collect Every Possible Outcome and Hope One Behaves
Another reliable path to statistical chaos is measuring everything: blood pressure, gene expression, mood, behavior, protein levels, left eyebrow angle, and whether the lab mouse looked judgmental on Tuesday. More data can be useful, but only when the study has a clear hierarchy of outcomes.
Without a prespecified primary outcome, analysis becomes a fishing expedition. The more tests you run, the easier it becomes to find something that looks exciting by chance. This is how “interesting trends” multiply like rabbits in a spreadsheet. A biostatistician can help decide which outcome is primary, which outcomes are secondary, and which are exploratory. That structure protects the study from overclaiming and helps readers trust the results.
4. Randomize “When Convenient”
Randomization is not the same as alternating groups, choosing the next available patient, assigning the first cage to treatment, or letting the intern decide because “she has good instincts.” Proper randomization reduces selection bias and helps balance known and unknown factors across groups.
In small experiments, simple randomization may still create imbalance, so methods such as blocking, stratification, or matched-pair randomization may be more appropriate. Your biostatistician can help choose a randomization method that fits the design. More importantly, they can help make sure the process is documented clearly enough that reviewers do not develop that special facial expression meaning, “Please explain this immediately.”
5. Treat Blinding as Optional Decoration
Blinding is not just for large clinical trials with glossy protocols. It matters whenever judgment can influence treatment delivery, measurement, scoring, data cleaning, or interpretation. If the person measuring the outcome knows which group received the intervention, bias can sneak in wearing a lab coat.
Sometimes full blinding is impossible. That does not mean the issue should be ignored. A biostatistician can help identify where blinding is most important, where allocation concealment is possible, and how to report unavoidable limitations honestly. Good design does not require perfection. It requires deliberate planning.
What a Biostatistician Actually Needs Before the Experiment
A productive biostatistics consultation does not require you to arrive with every answer. It does require enough information to have a serious design conversation. Think of the first meeting as a research design workout. Nobody expects you to bench-press a mixed-effects model on day one, but you should bring your scientific question, background, and best estimate of what you want to learn.
Bring a Clear Research Question
Start with the question in plain English. For example: “Does Drug A reduce tumor volume compared with placebo after six weeks?” is much better than “We want to look at treatment effects.” A clear question identifies the exposure or intervention, comparison group, population, outcome, and time frame.
Define the Experimental Unit
The experimental unit is the thing being independently assigned to treatment. In clinical research, it might be a patient. In animal research, it could be an animal, cage, litter, or tissue sample depending on the design. In laboratory studies, it may be a plate, batch, culture, or biological replicate. Confusing technical replicates with biological replicates is one of the fastest ways to create inflated confidence and disappointed reviewers.
Separate Primary, Secondary, and Exploratory Outcomes
Your primary outcome is the one the study is built to answer. Secondary outcomes add important supporting information. Exploratory outcomes are useful for generating future hypotheses. Labeling these categories before data collection prevents the awkward situation where the “primary outcome” mysteriously becomes whichever variable produced the smallest p-value.
Discuss the Minimum Meaningful Effect
A study can detect a statistically significant difference that is too small to matter. It can also miss a meaningful difference because it was underpowered. Before calculating sample size, decide what effect would change scientific understanding, clinical practice, policy, or the next experiment. This is not just math. It is judgment, context, and domain expertise.
How Poor Planning Damages Good Science
Bad design is expensive because it wastes more than money. It wastes samples, animals, participant trust, staff time, grant resources, and sometimes years of effort. Even worse, weak design can produce confident-looking results that are wrong. A beautiful graph cannot compensate for biased data collection, missing controls, or a sample size chosen by vibes.
Reproducibility problems often begin with design decisions that looked harmless at the time: no randomization, unclear exclusion criteria, unplanned subgroup analyses, flexible stopping rules, multiple outcomes without adjustment, and analysis choices made after seeing the data. These decisions do not always come from bad intentions. Usually, they come from rushing.
A biostatistician helps slow the process just enough to prevent scientific skidding. They ask annoying but useful questions: What is the primary comparison? What happens if data are missing? Are repeated measurements independent? Will batches confound treatment groups? Are males and females analyzed together or separately? Is the study confirmatory or exploratory? These questions may feel inconvenient, but they are cheaper than reviewer rejection.
Specific Examples of Statistical Trouble
The Underpowered Pilot That Became a “Negative Study”
A team runs a small pilot experiment with eight subjects per group and finds no statistically significant difference. They conclude the treatment does not work. The problem? The study was never powered to detect the expected effect. A nonsignificant result from a tiny study does not prove no effect. It may simply prove the study was too small to hear the signal over the noise.
The Spreadsheet With Missing Data Surprises
Another group collects patient outcomes over six months but never plans for missed visits. When the data arrive, several participants have incomplete measurements. Should they be excluded? Imputed? Modeled using all available observations? The answer depends on why the data are missing, how much is missing, and what assumptions are defensible. Planning ahead can prevent panic-cleaning, which is exactly as elegant as it sounds.
The Batch Effect That Wore a Fake Mustache
A lab processes all control samples on Monday and all treatment samples on Friday. Later, the treatment group looks different. Is that biology, or did Friday’s machine calibration quietly join the experiment? A biostatistician might have recommended balancing treatment groups across batches or including batch in the design and analysis plan. Without that planning, interpretation becomes foggy.
How to Consult Your Biostatistician the Right Way
Contact the biostatistician while the experiment is still flexible. The best time is when the hypothesis is clear enough to discuss but the protocol is not yet carved into stone. Bring a one-page summary if possible. Include the background, objective, study population, intervention or exposure, comparison group, outcome measures, timing, expected sample availability, constraints, and planned use of the results.
Be honest about limitations. If you can only recruit 30 participants, say so. If the assay is expensive, say so. If the animal facility has cage constraints, say so. Biostatisticians are not there to shame feasibility problems. They are there to design around them or tell you when the research question needs adjusting.
Ask for help building a statistical analysis plan before data collection begins. The plan should identify the primary analysis, covariates, subgroup analyses, handling of missing data, outlier rules, interim looks if any, and criteria for excluding observations. This does not eliminate exploration. It simply separates confirmatory analysis from discovery work.
A Practical Pre-Experiment Checklist
Before Your First Biostatistics Meeting
- Write the research question in one or two sentences.
- Identify the primary outcome and measurement time point.
- Define the experimental unit and unit of analysis.
- Describe treatment groups, controls, and allocation plans.
- Estimate the smallest meaningful effect size.
- Gather previous data or literature estimates for variability.
- List expected constraints, including budget, recruitment, assay costs, and timelines.
- Explain any planned randomization, blinding, blocking, or stratification.
- Describe anticipated missing data and dropout risks.
- Bring a draft data collection form or variable list.
This checklist may look simple, but it prevents the most common consultation failure: asking a biostatistician to solve an undefined problem. Clear inputs lead to useful statistical advice. Fuzzy inputs lead to philosophical conversations and more coffee.
What Not to Say in a Biostatistics Consultation
Some phrases make statisticians gently reach for their emergency tea. “We already collected the data, so the design is fixed.” “We measured 43 outcomes, but we will decide the main one later.” “We removed three outliers because they ruined the graph.” “The sample size is whatever we can afford, but we need 90% power.” “Can you just tell us which test gives the best p-value?”
These statements are not moral failures. They are design alarms. When they appear, the solution is not embarrassment. The solution is earlier collaboration, clearer documentation, and a shared commitment to answering the scientific question honestly.
Experience Notes: Lessons From Real-World Research Planning
In real research environments, the most successful projects are rarely the ones with the fanciest statistical method. They are the ones where the research team and biostatistician have a conversation early enough to make changes. I have seen projects improve dramatically after one basic question: “What is the primary outcome?” At first, the room gets quiet. Then someone says, “Well, we care about all of them.” That is understandable, but it is not a design. Once the team chooses one main outcome, the rest of the protocol becomes easier: sample size, analysis, data collection, and interpretation all begin to align.
Another common experience is watching teams discover that their data collection form does not match their research question. The lab may be measuring the outcome, but not the timing. The clinic may be recording medication use, but not dose changes. The survey may ask whether symptoms improved, but not when improvement occurred. These are not statistical mistakes in the narrow sense. They are design mistakes with statistical consequences. A biostatistician can often spot them before the first participant is enrolled.
One of the most valuable habits is documenting decisions before data collection. For example, decide what counts as an exclusion, what happens if a sample fails quality control, whether repeated measures will be averaged or modeled, and which covariates are scientifically justified. This protects the team from making rules after seeing inconvenient results. It also makes the manuscript stronger because reviewers can see that the analysis was not invented after the outcome was known.
Experience also teaches that collaboration works best when researchers treat the biostatistician as a scientific partner, not a calculator with shoes. The statistician does not replace subject-matter expertise. Instead, they help sharpen it into a design that can survive contact with data. The investigator knows the biology, clinical context, or public health problem. The biostatistician knows how design choices affect inference. The strongest studies combine both forms of expertise.
Finally, the best consultation meetings are honest about uncertainty. Maybe the expected effect size is unclear. Maybe previous studies disagree. Maybe recruitment will be difficult. That is not a reason to avoid planning. It is the reason planning matters. A good biostatistician can suggest sensitivity analyses for sample size, adaptive design options, pilot objectives, or a more realistic primary endpoint. The goal is not to make the experiment perfect. The goal is to make it answerable, transparent, and worth the effort.
Conclusion: Call Early, Save the Experiment
Learning how not to consult your biostatistician before doing an experiment is really a lesson in scientific humility. Do not wait until the data are collected. Do not ask for significance as if it were a sauce. Do not confuse more variables with better evidence. Do not treat randomization, blinding, sample size, and analysis planning as bureaucratic decorations.
Instead, invite the biostatistician while the study can still be improved. Bring the research question, the practical constraints, and the willingness to revise. The result will be a cleaner protocol, a stronger analysis plan, a more credible manuscript, and fewer late-night conversations with spreadsheets named “final_final_REALLY_final.xlsx.”
A well-designed experiment does not guarantee exciting results. It does something better: it makes the results trustworthy. And in science, trustworthy beats flashy every time.
